retatrutide health benefits 🚨 JUST RELEASED TODAY!!!! NEW PHASE 3 DATA Today, July 23, 2026, new Phase 3 retatrutide results were released, adding to what is already one of the most interesting obesity drug VisualAbstract: Retatrutide reduces body weight

Central nervous system effects: GLP-1 receptors are present in the brain, and their activation is hypothesised to influence neurological pathways associated with energy levels and alertness, though this mechanism has not been fully established in humans

GLP-1 receptor agonists in either form share the class boxed warning for thyroid C-cell tumor risk observed in rodent studies

As the central organ of cholesterol metabolism, the liver directly affects the bodys cholesterol metabolism homeostasis

ENJOY LASTING WEIGHT LOSS WITH GARD What is Retatrutide

Key Takeaways 3 DailyMed-approved sites: Abdomen, front or outer thigh, and upper arm (DailyMed RETATRUTIDE PEN label) Self-injection: Abdomen and thigh are suitable for self-administration

Appetite: Rate your hunger and satiety on a 1 to 10 scale before and after meals